
Maryam Monshipouri
Examiner (ID: 849)
| Most Active Art Unit | 1656 |
| Art Unit(s) | 1653, 1652, 1656, 1651 |
| Total Applications | 2170 |
| Issued Applications | 1561 |
| Pending Applications | 225 |
| Abandoned Applications | 434 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9589114
[patent_doc_number] => 08778652
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-07-15
[patent_title] => 'Pentose fermentation by a recombinant microorganism'
[patent_app_type] => utility
[patent_app_number] => 13/530311
[patent_app_country] => US
[patent_app_date] => 2012-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 81345
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13530311
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/530311 | Pentose fermentation by a recombinant microorganism | Jun 21, 2012 | Issued |
Array
(
[id] => 8542912
[patent_doc_number] => 08318198
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2012-11-27
[patent_title] => 'Pharmaceutical composition of nanoparticles'
[patent_app_type] => utility
[patent_app_number] => 13/527886
[patent_app_country] => US
[patent_app_date] => 2012-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 26
[patent_no_of_words] => 27190
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13527886
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/527886 | Pharmaceutical composition of nanoparticles | Jun 19, 2012 | Issued |
Array
(
[id] => 8591923
[patent_doc_number] => 08349799
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2013-01-08
[patent_title] => 'Pharmaceutical composition of nanoparticles'
[patent_app_type] => utility
[patent_app_number] => 13/525307
[patent_app_country] => US
[patent_app_date] => 2012-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 23
[patent_no_of_words] => 33156
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13525307
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/525307 | Pharmaceutical composition of nanoparticles | Jun 15, 2012 | Issued |
Array
(
[id] => 9413390
[patent_doc_number] => 08697426
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-04-15
[patent_title] => 'Contaminant control in Zymomonas fermentation using virginiamycin'
[patent_app_type] => utility
[patent_app_number] => 13/524255
[patent_app_country] => US
[patent_app_date] => 2012-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 11249
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13524255
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/524255 | Contaminant control in Zymomonas fermentation using virginiamycin | Jun 14, 2012 | Issued |
Array
(
[id] => 9041691
[patent_doc_number] => 20130244329
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-19
[patent_title] => 'mTOR Ligands and Polynucleotides Encoding mTOR Ligands'
[patent_app_type] => utility
[patent_app_number] => 13/491315
[patent_app_country] => US
[patent_app_date] => 2012-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 8592
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13491315
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/491315 | mTOR ligands and polynucleotides encoding mTOR ligands | Jun 6, 2012 | Issued |
Array
(
[id] => 10339174
[patent_doc_number] => 20150224179
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-13
[patent_title] => 'COMPOSITION CAPABLE OF IMPROVING STABILITY OF BACTERIOPHAGE LYSIN PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 14/404158
[patent_app_country] => US
[patent_app_date] => 2012-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3776
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14404158
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/404158 | Composition capable of improving stability of bacteriophage lysin proteins | May 28, 2012 | Issued |
Array
(
[id] => 9970967
[patent_doc_number] => 09017974
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-04-28
[patent_title] => 'Method for the synthesis of porphyrin-phospholipid conjugates'
[patent_app_type] => utility
[patent_app_number] => 14/125035
[patent_app_country] => US
[patent_app_date] => 2012-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 10
[patent_no_of_words] => 6856
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14125035
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/125035 | Method for the synthesis of porphyrin-phospholipid conjugates | May 24, 2012 | Issued |
Array
(
[id] => 9698984
[patent_doc_number] => 20140248670
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-04
[patent_title] => 'Methods for Enhancing the Degradation of Cellulosic Material with Chitin Binding Proteins'
[patent_app_type] => utility
[patent_app_number] => 14/117317
[patent_app_country] => US
[patent_app_date] => 2012-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39305
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14117317
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/117317 | Methods for enhancing the degradation of cellulosic material with chitin binding proteins | May 17, 2012 | Issued |
Array
(
[id] => 8994782
[patent_doc_number] => 08518667
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-08-27
[patent_title] => 'KEX2 cleavage regions of recombinant fusion proteins'
[patent_app_type] => utility
[patent_app_number] => 13/472296
[patent_app_country] => US
[patent_app_date] => 2012-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 13
[patent_no_of_words] => 17224
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 181
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13472296
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/472296 | KEX2 cleavage regions of recombinant fusion proteins | May 14, 2012 | Issued |
Array
(
[id] => 8359019
[patent_doc_number] => 20120214181
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-23
[patent_title] => 'ASSAY FOR PCSK9 INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 13/466418
[patent_app_country] => US
[patent_app_date] => 2012-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 12262
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13466418
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/466418 | ASSAY FOR PCSK9 INHIBITORS | May 7, 2012 | Abandoned |
Array
(
[id] => 8441560
[patent_doc_number] => 20120258176
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-11
[patent_title] => 'NANOPARTICLES FOR PROTEIN DRUG DELIVERY'
[patent_app_type] => utility
[patent_app_number] => 13/465793
[patent_app_country] => US
[patent_app_date] => 2012-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 29840
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13465793
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/465793 | Nanoparticles for protein drug delivery | May 6, 2012 | Issued |
Array
(
[id] => 8542915
[patent_doc_number] => 08318200
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2012-11-27
[patent_title] => 'Pharmaceutical composition of nanoparticles'
[patent_app_type] => utility
[patent_app_number] => 13/462699
[patent_app_country] => US
[patent_app_date] => 2012-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 21
[patent_no_of_words] => 24218
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13462699
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/462699 | Pharmaceutical composition of nanoparticles | May 1, 2012 | Issued |
Array
(
[id] => 9363157
[patent_doc_number] => 20140073030
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-13
[patent_title] => 'DETERGENT COMPOSITIONS CONTAINING BACILLUS AGARADHAERENS MANNANASE AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/114709
[patent_app_country] => US
[patent_app_date] => 2012-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 31002
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14114709
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/114709 | Detergent compositions containing Bacillus agaradhaerens mannanase and methods of use thereof | Apr 26, 2012 | Issued |
Array
(
[id] => 10187754
[patent_doc_number] => 09217165
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-12-22
[patent_title] => 'Mutant strain of lactic acid producing yeast and process for producing lactic acid'
[patent_app_type] => utility
[patent_app_number] => 14/114001
[patent_app_country] => US
[patent_app_date] => 2012-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 6516
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 133
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14114001
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/114001 | Mutant strain of lactic acid producing yeast and process for producing lactic acid | Apr 26, 2012 | Issued |
Array
(
[id] => 8478009
[patent_doc_number] => 20120277417
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-01
[patent_title] => 'ALGAL DESATURASES'
[patent_app_type] => utility
[patent_app_number] => 13/458914
[patent_app_country] => US
[patent_app_date] => 2012-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 2586
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13458914
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/458914 | Algal desaturases | Apr 26, 2012 | Issued |
Array
(
[id] => 9608000
[patent_doc_number] => 08785165
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-07-22
[patent_title] => 'Single pH process for starch liquefaction and saccharification for high-density glucose syrups'
[patent_app_type] => utility
[patent_app_number] => 14/113557
[patent_app_country] => US
[patent_app_date] => 2012-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10971
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14113557
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/113557 | Single pH process for starch liquefaction and saccharification for high-density glucose syrups | Apr 26, 2012 | Issued |
Array
(
[id] => 8372779
[patent_doc_number] => 20120222171
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-30
[patent_title] => 'NUCLEOTIDE SEQUENCES AND POLYPEPTIDES ENCODED THEREBY USEFUL FOR MODIFYING PLANT CHARACTERISTICS'
[patent_app_type] => utility
[patent_app_number] => 13/453954
[patent_app_country] => US
[patent_app_date] => 2012-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7287
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13453954
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/453954 | NUCLEOTIDE SEQUENCES AND POLYPEPTIDES ENCODED THEREBY USEFUL FOR MODIFYING PLANT CHARACTERISTICS | Apr 22, 2012 | Abandoned |
Array
(
[id] => 8328656
[patent_doc_number] => 08236752
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2012-08-07
[patent_title] => 'Pharmaceutical composition of nanoparticles'
[patent_app_type] => utility
[patent_app_number] => 13/453149
[patent_app_country] => US
[patent_app_date] => 2012-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 20
[patent_no_of_words] => 35594
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13453149
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/453149 | Pharmaceutical composition of nanoparticles | Apr 22, 2012 | Issued |
Array
(
[id] => 8870733
[patent_doc_number] => 08466110
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-06-18
[patent_title] => 'Use of an agent that restores tissue perfusion and oxygenation'
[patent_app_type] => utility
[patent_app_number] => 13/449932
[patent_app_country] => US
[patent_app_date] => 2012-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 13
[patent_no_of_words] => 19623
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13449932
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/449932 | Use of an agent that restores tissue perfusion and oxygenation | Apr 17, 2012 | Issued |
Array
(
[id] => 8328187
[patent_doc_number] => 08236281
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2012-08-07
[patent_title] => 'Pharmaceutical composition of nanoparticles'
[patent_app_type] => utility
[patent_app_number] => 13/449157
[patent_app_country] => US
[patent_app_date] => 2012-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 20
[patent_no_of_words] => 33662
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13449157
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/449157 | Pharmaceutical composition of nanoparticles | Apr 16, 2012 | Issued |